The American Journal of Medicine
Volume 123, Issue 5 , Pages 432-438 , May 2010

Altered Cardiac Autonomic Function May Precede Insulin Resistance in Metabolic Syndrome

  • Chih-Jen Chang, MD

      Affiliations

    • Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Department of Family Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Yi-Ching Yang, MD, MPH

      Affiliations

    • Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Department of Family Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Feng-Hwa Lu, MD, MS

      Affiliations

    • Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Department of Family Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Thy-Sheng Lin, MD, MS

      Affiliations

    • Department of Neurology, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Jia-Jin Chen, PhD

      Affiliations

    • Institute of Biomedical Engineering, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Tzung-Lieh Yeh, MD

      Affiliations

    • Department of Psychiatry, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • ,
  • Chih-Hsing Wu, MD

      Affiliations

    • Department of Family Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • ,
  • Jin-Shang Wu, MD, MS

      Affiliations

    • Department of Family Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan
    • Department of Family Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
    • Corresponding Author InformationRequests for reprints should be addressed to Jin-Shang Wu, MD, MS, Department of Family Medicine, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 70403, Taiwan, ROC

References 

  1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421
  2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome (An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement). Circulation. 2005;112:2735–2752
  3. Boyko EJ, de Courten M, Zimmet PZ, et al. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care. 2000;23:1242–1248
  4. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care. 2003;26:3153–3159
  5. Wang JJ, Qiao Q, Miettinen ME, et al. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care. 2004;27:2429–2437
  6. Hunt KJ, Resendez RG, Williams K, et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004;110:1251–1257
  7. Malik S, Wong ND, Franklin S, et al. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care. 2005;28:690–693
  8. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385–390
  9. Tan CE, Ma S, Wai D, et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care. 2004;27:1182–1186
  10. Mancia G, Bousquet P, Elghozi JL, et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens. 2007;25:909–920
  11. Esler M, Straznicky N, Eikelis N, et al. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension. 2006;48:787–796
  12. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Circulation. 1996;93:1043–1065
  13. Huggett RJ, Burns J, Mackintosh AF, Mary DA. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension. 2004;44:847–852
  14. Grassi G, Dell'Oro R, Quarti-Trevano F, et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia. 2005;48:1359–1365
  15. Brunner EJ, Hemingway H, Walker BR, et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation. 2002;106:2659–2665
  16. Liao D, Sloan RP, Cascio WE, et al. Multiple metabolic syndrome is associated with lower heart rate variability (The Atherosclerosis Risk in Communities Study). Diabetes Care. 1998;21:2116–2122
  17. Lu FH, Yang YC, Wu JS, et al. A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med. 1998;15:564–572
  18. Paffenbarger RS, Blair SN, Lee IM, Hyde RT. Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc. 1993;25:60–70
  19. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–419
  20. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens. 1997;10:77–83
  21. Flaa A, Aksnes TA, Kjeldsen SE, Eide I, Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism. 2008;57:1422–1427
  22. Carnethon MR, Prineas RJ, Temprosa M, et al. Diabetes Prevention Program Research Group The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006;29:914–919
  23. Jamerson KA, Julius S, Gudbrandsson T, et al. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension. 1993;21:618–623
  24. Egan BM. Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture. Int J Obes. 1991;15:133–139
  25. Baron AD, Laakso M, Brechtel G, et al. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab. 1997;70:1525–1533
  26. Julius S, Gundrandsson T, Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Press. 1992;1:9–19
  27. Benthem L, Keizer K, Wiegman CH, et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol-Endocrinol Metab. 2000;279:E1286–E1293
  28. Mackintosh VS, Phan CT, Mortimer BC, Redgrave TG. Vasoactive mediators affect the clearance of lipids from emulsion models of plasma lipoproteins in rats. J Cardiovasc Pharmacol. 1996;27:447–454
  29. Wu JS, Lu FH, Yang YC, et al. Epidemiological study on the effect of pre-hypertension and family history of hypertension on cardiac autonomic function. J Am Coll Cardiol. 2008;51:1896–1901
  30. Wu JS, Lu FH, Yang YC, et al. Epidemiological evidence of altered cardiac autonomic function in overweight, but not underweight subjects. Int J Obes Relat Metab Disord. 2008;32:788–794
  31. Wu JS, Yang YC, Lin TS, et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab. 2007;92:3885–3889
  32. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med. 2005;56:45–62

 Funding: This study was supported by grants from the National Science Council, Taiwan, R.O.C. (NSC 87-2314-B-006-084, NSC 89-2314-B-006-043, and NSC92-2314-B-006-117).

 Conflict of Interest: There are no conflicts of interest.

 Authorship: All authors had access to the data and a role in writing the article. C.-J. Chang and Y.-C. Yang contributed equally to this work.

PII: S0002-9343(09)01057-2

doi: 10.1016/j.amjmed.2009.07.031

The American Journal of Medicine
Volume 123, Issue 5 , Pages 432-438 , May 2010

Article Tools

* Image Usage & Resolution